Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamera J Corte

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
Chest|January 9, 2023
Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and AustralasiaDeborah Assayag, Ayodeji Adegunsoye, Robert Sheehy, et al.
American Journal of Respiratory and Critical Care Medicine|July 20, 2021
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research StatementKerri I Aronson, Sonye K Danoff, Anne-Marie Russell, et al.
The Lancet. Respiratory Medicine|July 18, 2024
Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validationHernan P Fainberg, Yuben Moodley, Isaac Triguero, et al.
Chest|July 1, 2021
Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey InitiativeGary M Hunninghake, Jonathan G Goldin, Michael A Kadoch, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2022
Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed TomographySimon L F Walsh, John A Mackintosh, Lucio Calandriello, et al.
American Journal of Respiratory and Critical Care Medicine|April 4, 2024
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision MedicineAyodeji Adegunsoye, Jonathan A Kropski, Juergen Behr, et al.
Clinical and Experimental Rheumatology|February 28, 2022
Defining anti-synthetase syndrome: a systematic literature reviewGiovanni Zanframundo, Sara Faghihi-Kashani, Carlo Alberto Scirè, et al.
The Lancet. Respiratory Medicine|March 1, 2026
Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a multicentre, randomised, sham-controlled trialAnne E Holland, Mariana Hoffman, Tamera J Corte, et al.
The Medical Journal of Australia|February 2, 2018
Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summaryHelen E Jo, Jyotika D Prasad, Lauren K Troy, et al.
Respirology (Carlton, Vic.)|October 18, 2018
Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis RegistryHelen E Jo, Ian Glaspole, Nicole Goh, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Chest|January 9, 2023
Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and AustralasiaDeborah Assayag, Ayodeji Adegunsoye, Robert Sheehy, et al.
American Journal of Respiratory and Critical Care Medicine|July 20, 2021
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research StatementKerri I Aronson, Sonye K Danoff, Anne-Marie Russell, et al.
The Lancet. Respiratory Medicine|July 18, 2024
Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validationHernan P Fainberg, Yuben Moodley, Isaac Triguero, et al.
Chest|July 1, 2021
Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey InitiativeGary M Hunninghake, Jonathan G Goldin, Michael A Kadoch, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2022
Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed TomographySimon L F Walsh, John A Mackintosh, Lucio Calandriello, et al.
American Journal of Respiratory and Critical Care Medicine|April 4, 2024
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision MedicineAyodeji Adegunsoye, Jonathan A Kropski, Juergen Behr, et al.
Clinical and Experimental Rheumatology|February 28, 2022
Defining anti-synthetase syndrome: a systematic literature reviewGiovanni Zanframundo, Sara Faghihi-Kashani, Carlo Alberto Scirè, et al.
The Lancet. Respiratory Medicine|March 1, 2026
Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a multicentre, randomised, sham-controlled trialAnne E Holland, Mariana Hoffman, Tamera J Corte, et al.
The Medical Journal of Australia|February 2, 2018
Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summaryHelen E Jo, Jyotika D Prasad, Lauren K Troy, et al.
Respirology (Carlton, Vic.)|October 18, 2018
Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis RegistryHelen E Jo, Ian Glaspole, Nicole Goh, et al.
Pageof 16